2023
Trends in mortality and causes of death among Chinese adolescents aged 10–19 years from 1990 to 2019
Zhu J, Li Y, Zhang C, He J, Niu L. Trends in mortality and causes of death among Chinese adolescents aged 10–19 years from 1990 to 2019. Frontiers In Public Health 2023, 11: 1075858. PMID: 36825144, PMCID: PMC9941149, DOI: 10.3389/fpubh.2023.1075858.Peer-Reviewed Original ResearchConceptsNon-communicable diseasesNon-communicable disease mortality ratesAdolescent HealthRates of non-communicable diseasesGlobal Burden of Disease StudyMortality rateBurden of Disease StudyPromote adolescent healthChinese adolescentsAdolescent mortality ratesAdolescent mortalityGlobal burdenRoad injuriesSelf-harmHealthy ChinaAge disparitiesHigher mortalityDisease StudyMedical practiceCongenital birth defectsSocioeconomic conditionsHealthRate of communicationDisease patternsNutritional diseases
2021
Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers
Zhang Y, Tedrow J, Nouraie M, Li X, Chandra D, Bon J, Kass DJ, Fuhrman CR, Leader JK, Duncan SR, Kaminski N, Sciurba FC. Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers. Thorax 2021, 76: 335-342. PMID: 33479043, PMCID: PMC8249179, DOI: 10.1136/thoraxjnl-2020-215356.Peer-Reviewed Original ResearchConceptsAirflow obstructionPlasma levelsLung tissueEmphysema severitySmoking-related lung diseaseAssociation of lungExpiratory airflow obstructionFormer tobacco smokersLevels of PTX3PTX3 gene expressionElevated plasma levelsHyaluronic acid levelsBlood of subjectsPlasma PTX3PTX3 levelsLung functionTobacco exposureClinical outcomesTobacco smokersLung diseasePentraxin 3Predictive biomarkersPTX3 expressionLower riskDisease patterns
2020
Defining High‐risk Emergency Chief Complaints: Data‐driven Triage for Low‐ and Middle‐income Countries
Rice B, Leanza J, Mowafi H, Kamara N, Mulogo EM, Bisanzo M, Nikam K, Kizza H, Newberry JA, Strehlow M, Group G, Kohn M. Defining High‐risk Emergency Chief Complaints: Data‐driven Triage for Low‐ and Middle‐income Countries. Academic Emergency Medicine 2020, 27: 1291-1301. PMID: 32416022, PMCID: PMC7818254, DOI: 10.1111/acem.14013.Peer-Reviewed Original ResearchConceptsHigh-risk chief complaintsChief complaintMiddle-income countriesPatient outcomesLMIC settingsVital signsMortality odds ratioLevel of consciousnessLogistic regression modelsLocal disease patternsHIV statusMortality oddsOdds ratioDerivation data setsEmergency unitMortality riskEmergency careEmergency training programsDerivation dataDisease patternsTriage systemRisk categoriesComplaintsPatient dataTriage data
2015
Association Between Local Pediatric Vaccination Rates and Patterns of Pneumococcal Disease in Adults
Pingali SC, Warren JL, Mead AM, Sharova N, Petit S, Weinberger DM. Association Between Local Pediatric Vaccination Rates and Patterns of Pneumococcal Disease in Adults. The Journal Of Infectious Diseases 2015, 213: 509-515. PMID: 26310307, PMCID: PMC4721904, DOI: 10.1093/infdis/jiv431.Peer-Reviewed Original ResearchConceptsInvasive pneumococcal diseasePneumococcal diseaseIPD casesPopulation-based surveillance systemZip code level dataAdult IPD casesDoses of PCV7Effectiveness of PCVsPediatric vaccination ratesVaccination of childrenState immunization registryZip codesLogistic regression modelsPCV7 serotypesHigher proportionVaccination ratesImmunization registryDisease patternsDiseaseAdultsPCV7PCVSerotypesChildrenDosesThromboangiitis Obliterans
Tabtabai S, Beckman J. Thromboangiitis Obliterans. 2015, 3031-3041. DOI: 10.1007/978-3-642-37078-6_114.Peer-Reviewed Original ResearchRisk of amputationImprove quality of lifeCessation of smokingQuality of lifeIncidence of smokingPeriods of disease activityYoung male smokersImprove qualityMale smokersDisease activityChronic inflammationDecreased incidenceIschemic ulcersAcute thrombosisVascular insufficiencyDisease patternsSmokingSmall arteriesBuerger's diseaseThromboangiitis obliteransDisease
2014
Thromboangiitis Obliterans (Buerger’s Disease)
Tabtabai S, Beckman J. Thromboangiitis Obliterans (Buerger’s Disease). 2014, 1-12. DOI: 10.1007/978-3-642-37393-0_114-1.Peer-Reviewed Original ResearchRisk of amputationImprove quality of lifeCessation of smokingQuality of lifeIncidence of smokingPeriods of disease activityYoung male smokersImprove qualityMale smokersDisease activityChronic inflammationDecreased incidenceIschemic ulcersAcute thrombosisVascular insufficiencyDisease patternsSmokingBuerger's diseaseSmall arteriesThromboangiitis obliteransDisease
2004
Therapeutic goals in the treatment of Gaucher disease
Pastores GM, Weinreb NJ, Aerts H, Andria G, Cox TM, Giralt M, Grabowski GA, Mistry PK, Tylki-Szymańska A. Therapeutic goals in the treatment of Gaucher disease. Seminars In Hematology 2004, 41: 4-14. PMID: 15468045, DOI: 10.1053/j.seminhematol.2004.07.009.Peer-Reviewed Original ResearchConceptsEnzyme replacement therapyGaucher diseaseTherapeutic responseTherapeutic goalsNon-neuronopathic (type 1) Gaucher diseaseType 1 Gaucher diseaseVariable disease patternGoal of treatmentCommon lysosomal storage disorderEvidence-based consensusExtensive clinical experienceQuality of lifeImplementation of treatmentLysosomal storage disorderPulmonary diseaseReplacement therapyMultisystem conditionIndividualized managementIndividual patientsClinical experienceDisease patternsGrowth retardationDiseaseStorage disorderSkeletal pathology
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply